| Medical and Health Sciences | Lifetime | 27 | AU 2 | 100.00 |
| Medical and Health Sciences | 2021-2025 | 203 | AU 8 | 99.96 |
| Rheumatology | Lifetime | 1 | AU 1 | 99.99 |
| Surgery | Lifetime | 78 | AU 4 | 99.93 |
| Genetics | Lifetime | 120 | AU 8 | 99.74 |
| Public, Environmental and Occupational Health | Lifetime | 180 | AU 10 | 99.74 |
| Clinical Pharmacology | Lifetime | 67 | AU 7 | 99.72 |
| General Health Professions | Lifetime | 401 | AU 26 | 99.53 |
| Pathology and Forensic Medicine | Lifetime | 158 | AU 4 | 99.36 |
| Biomedical Engineering | Lifetime | 787 | AU 37 | 98.84 |
| Oncology | Lifetime | 670 | AU 18 | 98.68 |
| Nutrition and Dietetics | Lifetime | 539 | AU 24 | 97.60 |
| Pediatrics, Perinatology and Child Health | Lifetime | 797 | AU 38 | 97.36 |
| Orthopedics and Sports Medicine | Lifetime | 384 | AU 40 | 96.74 |
| Health, Toxicology and Mutagenesis | Lifetime | 821 | AU 33 | 95.99 |
| Dermatology | Lifetime | 567 | AU 11 | 95.24 |
| Reproductive Medicine | Lifetime | 602 | AU 30 | 94.77 |
| Cancer Research | Lifetime | 854 | AU 20 | 93.61 |
| Obstetrics and Gynecology | Lifetime | 555 | AU 27 | 94.69 |
| Emergency Medicine | Lifetime | 832 | AU 44 | 90.26 |
| Nephrology | Lifetime | 691 | AU 37 | 90.69 |
| Radiological and Ultrasound Technology | Lifetime | 503 | AU 39 | 88.52 |
| Rehabilitation | Lifetime | 917 | AU 75 | 69.13 |
| Rheumatology | 2021-2025 | 4 | AU 1 | 99.90 |
| Surgery | 2021-2025 | 93 | AU 4 | 99.46 |
| General Health Professions | 2021-2025 | 161 | AU 13 | 98.87 |
| Clinical Pharmacology | 2021-2025 | 44 | AU 8 | 98.22 |
| Medical Physiology | 2021-2025 | 573 | AU 28 | 91.22 |
| Orthopedics and Sports Medicine | 2021-2025 | 310 | AU 35 | 81.63 |
| Psychiatry and Mental health | 2021-2025 | 726 | AU 50 | 73.92 |
| Osteoarthritis Treatment and Mechanisms | Lifetime | 1 | AU 1 | 99.99 |
| Lower Extremity Biomechanics and Pathologies | Lifetime | 3 | AU 2 | 99.94 |
| Inflammatory mediators and NSAID effects | Lifetime | 7 | AU 1 | 99.88 |
| Total Knee Arthroplasty Outcomes | Lifetime | 10 | AU 1 | 99.92 |
| Nutrition, Genetics, and Disease | Lifetime | 8 | AU 1 | 99.77 |
| Knee injuries and reconstruction techniques | Lifetime | 16 | AU 1 | 99.86 |
| Folate and B Vitamins Research | Lifetime | 21 | AU 2 | 99.43 |
| Hip disorders and treatments | Lifetime | 14 | AU 1 | 99.72 |
| Musculoskeletal pain and rehabilitation | Lifetime | 55 | AU 8 | 99.76 |
| Musculoskeletal synovial abnormalities and treatments | Lifetime | 11 | AU 1 | 99.69 |
| Rheumatoid Arthritis Research and Therapies | Lifetime | 41 | AU 1 | 99.76 |
| Genetic Associations and Epidemiology | Lifetime | 48 | AU 4 | 99.58 |
| Epigenetics and DNA Methylation | Lifetime | 174 | AU 1 | 99.42 |
| Bone and Joint Diseases | Lifetime | 45 | AU 3 | 99.57 |
| Nutritional Studies and Diet | Lifetime | 86 | AU 2 | 99.59 |
| BRCA gene mutations in cancer | Lifetime | 71 | AU 8 | 99.25 |
| Cancer Risks and Factors | Lifetime | 56 | AU 1 | 99.52 |
| Clinical practice guidelines implementation | Lifetime | 63 | AU 5 | 98.95 |
| Spine and Intervertebral Disc Pathology | Lifetime | 291 | AU 15 | 99.01 |
| Estrogen and related hormone effects | Lifetime | 412 | AU 11 | 98.41 |
| Skin Protection and Aging | Lifetime | 175 | AU 14 | 98.13 |
| Tendon Structure and Treatment | Lifetime | 298 | AU 15 | 97.80 |
| Shoulder Injury and Treatment | Lifetime | 722 | AU 33 | 97.81 |
| Vitamin D Research Studies | Lifetime | 392 | AU 31 | 97.21 |
| HIV/AIDS Research and Interventions | Lifetime | 960 | AU 32 | 97.90 |
| HIV-related health complications and treatments | Lifetime | 321 | AU 12 | 97.39 |
| Fibromyalgia and Chronic Fatigue Syndrome Research | Lifetime | 400 | AU 28 | 96.50 |
| Gout, Hyperuricemia, Uric Acid | Lifetime | 196 | AU 4 | 95.86 |
| HIV/AIDS Impact and Responses | Lifetime | 165 | AU 7 | 96.21 |
| Selenium in Biological Systems | Lifetime | 267 | AU 6 | 96.22 |
| Adolescent Sexual and Reproductive Health | Lifetime | 706 | AU 30 | 96.95 |
| Global Public Health Policies and Epidemiology | Lifetime | 443 | AU 47 | 95.38 |
| Antioxidant Activity and Oxidative Stress | Lifetime | 793 | AU 17 | 95.80 |
| Carcinogens and Genotoxicity Assessment | Lifetime | 911 | AU 12 | 95.98 |
| Nonmelanoma Skin Cancer Studies | Lifetime | 583 | AU 51 | 94.99 |
| Spondyloarthritis Studies and Treatments | Lifetime | 505 | AU 10 | 95.38 |
| Medical and Biological Sciences | Lifetime | 838 | AU 22 | 91.30 |
| Pregnancy and Medication Impact | Lifetime | 905 | AU 52 | 92.45 |
| Glutathione Transferases and Polymorphisms | Lifetime | 641 | AU 17 | 92.03 |
| Musculoskeletal Disorders and Rehabilitation | Lifetime | 442 | AU 21 | 89.48 |
| Pharmacology and Obesity Treatment | Lifetime | 878 | AU 36 | 91.64 |
| Healthcare Systems and Challenges | Lifetime | 256 | AU 12 | 82.99 |
| Health Services Management and Policy | Lifetime | 213 | AU 14 | 80.56 |
| Pharmacological Effects of Medicinal Plants | Lifetime | 618 | AU 15 | 72.47 |
| Reliability and Agreement in Measurement | Lifetime | 795 | AU 33 | 55.35 |
| Osteoarthritis Treatment and Mechanisms | 2021-2025 | 1 | AU 1 | 99.90 |
| Inflammatory mediators and NSAID effects | 2021-2025 | 1 | AU 1 | 99.58 |
| Knee injuries and reconstruction techniques | 2021-2025 | 34 | AU 5 | 99.03 |
| Total Knee Arthroplasty Outcomes | 2021-2025 | 56 | AU 2 | 99.04 |
| Rheumatoid Arthritis Research and Therapies | 2021-2025 | 44 | AU 1 | 98.92 |
| Musculoskeletal pain and rehabilitation | 2021-2025 | 90 | AU 17 | 98.53 |
| Hip disorders and treatments | 2021-2025 | 30 | AU 2 | 98.06 |
| Clinical practice guidelines implementation | 2021-2025 | 20 | AU 4 | 97.10 |
| Lower Extremity Biomechanics and Pathologies | 2021-2025 | 66 | AU 8 | 97.27 |
| Tendon Structure and Treatment | 2021-2025 | 93 | AU 4 | 95.53 |
| Health Systems, Economic Evaluations, Quality of Life | 2021-2025 | 764 | AU 85 | 94.13 |
| Fibromyalgia and Chronic Fatigue Syndrome Research | 2021-2025 | 198 | AU 12 | 92.40 |
| Musculoskeletal synovial abnormalities and treatments | 2021-2025 | 82 | AU 1 | 89.59 |
| Pain Mechanisms and Treatments | 2021-2025 | 292 | AU 12 | 91.82 |
| Pharmacology and Obesity Treatment | 2021-2025 | 230 | AU 10 | 83.00 |
| Bone and Joint Diseases | 2021-2025 | 639 | AU 8 | 76.72 |
| Health Literacy and Information Accessibility | 2021-2025 | 925 | AU 82 | 66.07 |
| Social Media in Health Education | 2021-2025 | 792 | AU 60 | 62.32 |
| Musculoskeletal Disorders and Rehabilitation | 2021-2025 | 993 | AU 65 | 35.80 |
